Carthronix, Inc.

Philadelphia, PA

UEI
H35NAFC832C3
CAGE
7J1X4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1334 E Susquehanna Ave, Philadelphia, PA 19125, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Clinical assessment of CX-011 for pain relief, increased function, and potential disease-modifying treatment for knee… HT94252310289 Defense Health Agency $488,483
Advancement of a lead small molecule GP130 modulator for improving outcomes in joint fibrosis R43AR080485 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $467,400

Quick answers

Is Carthronix, Inc. registered in SAM.gov?

Yes. Carthronix, Inc.'s SAM.gov registration is active through June 22, 2027.

What is Carthronix, Inc.'s most recent federal award?

Carthronix, Inc.'s most recent federal grant award is Clinical assessment of CX-011 for pain relief, increased function, and potential disease-modifying treatment for knee… (HT94252310289), from Defense Health Agency, on May 1, 2023.

On GovTribe

See Carthronix, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login